The cryopreservation of hematopoietic stem cells can be used for rescuing the hematopoiesis after high dose chemotherapy. PURPOSE. The ice cristal formation during the freezing procedure is the key point that can be harmful to the cells. The cryopreservation of hematopoietic stem cells in a controlled-rate freezer could decrease the cell damage. METHODS. Twenty-three patients with a median age of 26 years (range 03-57) had bone marrow and/or peripheral blood stem cells harvested from March 1993 through October 1994, ending up to 86 freezing procedures. The patient's diagnoses are as follows: Non-Hodgkin's Lymphoma (n=5); Acute Myelogenous Leukemia (n=8); Acute Lymphocytic Leukemia (n=6); Hodgkin's disease (n=3); Multiple Myeloma (n=1). The cells were frozen away in a controlled-rate freezer chamber at the folowing rate: -1°C/min from room temperature to -45°C and then, at -10°C/min down to -80°C. After freezing, the cells were kept into mechanical freezers until the marrow infusion. To mobilize PBSC (peripheral blood stem cells), G-CSF (granulocyte colony stimulating factor) was given. RESULTS. A median of 3.16x10(8) cells/kg (range 0.86-24.22) of PBSC and 2.03x10(8) cells/kg (0.19-12.21) of bone marrow cells were frozen. The median time to reach granulocytes greater than 500/µL and platelets greater than 20,000/µL was 12 days (range 8-40) and 31 days (range 8-80), respectively. All patients had marrow engraftment after infusion of hematopoietic stem cells. CONCLUSION. The cryopreservation procedure using a controlled-rate freezer can store hematopoietic stem cells and potentially, cause less damage to the cells.
Bone marrow transplantation; Cryopreservation; Stem cell
